Resources Contact Us Home
Modified factor VIII

Image Number 6 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Secure access to customer log data in a multi-tenant environment
Method of predicting a motion vector for a current block in a current picture
Portable massage apparatus
Method of forming micropattern, method of forming damascene metallization, and semiconductor device and semiconductor memory device fabricated using the same
Printing system, information processing apparatus, print job processing method, information processing method, program, and storage medium
Display screen with an animated graphical user interface
Battery cell separator
  Randomly Featured Patents
Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
Low-cost laser diode array
Medicine supply apparatus
Thermostat assembly
Combination ladder and stair
Volumetric fluid dispensing apparatus
N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
Emulsion ink
Monolithic catalyst converter
Interspaced flush lighting assembly